Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Second Quarter ended June 30, 2026
Context: The Company issued a press release announcing unaudited financial results and operational highlights for the period.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) containing the detailed financial data. The filing text itself does not provide specific values for the following metrics:
- Revenue: Not stated in filing text.
- Profit: Not stated in filing text.
- Cash Flow: Not stated in filing text.
- Margins: Not stated in filing text.
- Debt and Liquidity: Not stated in filing text.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company announced operational highlights alongside financial results, though specific commentary is not included in the 8-K text.
Guidance and Outlook: No forward-looking guidance or outlook is provided in the filing text.
Risks and Contingencies: No specific risks or contingencies are detailed in the filing text.
Unusual Items: No unusual items are described in the filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q2 2026.
- Verify year-over-year and quarter-over-quarter growth rates in the press release.
- Check for updated full-year 2026 guidance or operational targets in the press release.
- Confirm the status of liquidity and debt covenants as detailed in the unaudited results.